Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach

This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science]

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Asaduzzaman, Md., Rahman, Md. Rezowanur, Rahman Khan, Md. Saifur, Islam, S.M. Ashraful
Άλλοι συγγραφείς: Department of Mathematics and Natural Sciences, BRAC University
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: © 2011 Journal of Applied Pharmaceutical Science 2016
Θέματα:
Διαθέσιμο Online:http://hdl.handle.net/10361/7113
id 10361-7113
record_format dspace
spelling 10361-71132016-12-04T10:11:50Z Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach Asaduzzaman, Md. Rahman, Md. Rezowanur Rahman Khan, Md. Saifur Islam, S.M. Ashraful Department of Mathematics and Natural Sciences, BRAC University Kinetic approach Methocel K4M CR Ranolazine Sustained release This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science] In this study an attempt was made to design and evaluate oral sustained release matrix tablets of ranolazine using Methocel K4M CR as the retardant polymer. Tablets were prepared by conventional wet granulation technique. Tablets were evaluated for parameters such as weight variation, hardness, friability and drug content. All the formulations showed compliance with pharmacopieal standards. In vitro release studies were performed using USP type II apparatus (paddle method) in 900 mL of 0.1N HCl at 50 rpm for 8 hours. The release kinetics was analyzed using the zero-order, first order, Higuchi, Hixson-Crowell and Korsmeyer-Peppas equations to explore and explain the mechanism of drug release from the matrix tablets. In vitro release studies revealed that percent drug release decreased with increase of polymer loading. Based on the dissolution data comparison with innovator brand F-5 formulation (16% Methocel K4M CR w/w of drug) was elected as the best formulation. The drug release profile of the best formulation was well controlled and uniform throughout the dissolution studies. The drug release of optimized formulation follows the Higuchi kinetic model (R2 = 0.99) and the mechanism is found to be non-Fickian/anomalous according to Korsmeyer-Peppas equation. All the formulations were checked for stability as per ICH guidelines and formulations were found stable during the study. Published 2016-12-04T10:10:18Z 2016-12-04T10:10:18Z 2011-10 Article Asaduzzaman, M., Rahman, M. R., Rahman Khan, M. S., & Ashraful Islam, S. M. (2011). Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach. Journal of Applied Pharmaceutical Science, 1(8), 131-136. 22313354 http://hdl.handle.net/10361/7113 en © 2011 Journal of Applied Pharmaceutical Science
institution Brac University
collection Institutional Repository
language English
topic Kinetic approach
Methocel K4M CR
Ranolazine
Sustained release
spellingShingle Kinetic approach
Methocel K4M CR
Ranolazine
Sustained release
Asaduzzaman, Md.
Rahman, Md. Rezowanur
Rahman Khan, Md. Saifur
Islam, S.M. Ashraful
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
description This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science]
author2 Department of Mathematics and Natural Sciences, BRAC University
author_facet Department of Mathematics and Natural Sciences, BRAC University
Asaduzzaman, Md.
Rahman, Md. Rezowanur
Rahman Khan, Md. Saifur
Islam, S.M. Ashraful
format Article
author Asaduzzaman, Md.
Rahman, Md. Rezowanur
Rahman Khan, Md. Saifur
Islam, S.M. Ashraful
author_sort Asaduzzaman, Md.
title Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
title_short Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
title_full Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
title_fullStr Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
title_full_unstemmed Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
title_sort development of sustain release matrix tablet of ranolazine based on methocel k4m cr: in vitro drug release and kinetic approach
publisher © 2011 Journal of Applied Pharmaceutical Science
publishDate 2016
url http://hdl.handle.net/10361/7113
work_keys_str_mv AT asaduzzamanmd developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach
AT rahmanmdrezowanur developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach
AT rahmankhanmdsaifur developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach
AT islamsmashraful developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach
_version_ 1814307530555260928